HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
HIMS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While HIMS has a great health rating, its profitability is only average at the moment. HIMS shows excellent growth, but is valued quite expensive already. These ratings would make HIMS suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 17.81%, HIMS belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
HIMS has a Return On Equity of 26.44%. This is amongst the best in the industry. HIMS outperforms 91.18% of its industry peers.
HIMS has a better Return On Invested Capital (10.98%) than 85.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.81% | ||
| ROE | 26.44% | ||
| ROIC | 10.98% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of HIMS (8.54%) is better than 91.18% of its industry peers.
Looking at the Operating Margin, with a value of 4.58%, HIMS is in line with its industry, outperforming 56.86% of the companies in the same industry.
HIMS's Gross Margin of 79.45% is amongst the best of the industry. HIMS outperforms 93.14% of its industry peers.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 8.54% | ||
| GM | 79.45% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HIMS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 22.45 indicates that HIMS is not in any danger for bankruptcy at the moment.
HIMS has a Altman-Z score of 22.45. This is amongst the best in the industry. HIMS outperforms 98.04% of its industry peers.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 22.45 |
ROIC/WACC1.24
WACC8.83%
2.3 Liquidity
A Current Ratio of 1.79 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS has a Current ratio of 1.79. This is in the better half of the industry: HIMS outperforms 66.67% of its industry peers.
HIMS has a Quick Ratio of 1.50. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a Quick ratio (1.50) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 590.91% over the past year.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.48% on average per year.
Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 69.33%.
The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)590.91%
EPS 3YN/A
EPS 5Y60.48%
EPS Q2Q%1000%
Revenue 1Y (TTM)69.33%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%95.45%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 27.61% on average per year.
EPS Next Y15.95%
EPS Next 2Y29.78%
EPS Next 3Y33.96%
EPS Next 5Y41.75%
Revenue Next Year58.8%
Revenue Next 2Y37.44%
Revenue Next 3Y31.76%
Revenue Next 5Y27.61%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 61.30, HIMS can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as HIMS.
Compared to an average S&P500 Price/Earnings ratio of 28.88, HIMS is valued quite expensively.
HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 52.86.
The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 21.20, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.3 | ||
| Fwd PE | 52.86 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS indicates a slightly more expensive valuation: HIMS is more expensive than 63.73% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as HIMS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.08 | ||
| EV/EBITDA | 87.49 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 33.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.84
PEG (5Y)1.01
EPS Next 2Y29.78%
EPS Next 3Y33.96%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
33.1
-1.94 (-5.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners79.43%
Inst Owner Change0.58%
Ins Owners11.03%
Ins Owner Change8.23%
Market Cap7.35B
Analysts69.09
Price Target45.39 (37.13%)
Short Float %32.23%
Short Ratio2.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)335.74%
Min EPS beat(2)4.62%
Max EPS beat(2)666.87%
EPS beat(4)4
Avg EPS beat(4)254.41%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.79%
EPS beat(12)10
Avg EPS beat(12)104.65%
EPS beat(16)11
Avg EPS beat(16)63.18%
Revenue beat(2)2
Avg Revenue beat(2)1.65%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)0.3%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)1.27%
Revenue beat(12)10
Avg Revenue beat(12)3.08%
Revenue beat(16)14
Avg Revenue beat(16)3.66%
PT rev (1m)5.2%
PT rev (3m)62.89%
EPS NQ rev (1m)3.1%
EPS NQ rev (3m)-8.17%
EPS NY rev (1m)1.4%
EPS NY rev (3m)13.8%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)7.83%
Revenue NY rev (1m)2.55%
Revenue NY rev (3m)13.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.3 | ||
| Fwd PE | 52.86 | ||
| P/S | 4.98 | ||
| P/FCF | 37.08 | ||
| P/OCF | 29.29 | ||
| P/B | 15.43 | ||
| P/tB | 22.94 | ||
| EV/EBITDA | 87.49 |
EPS(TTM)0.54
EY1.63%
EPS(NY)0.63
Fwd EY1.89%
FCF(TTM)0.89
FCFY2.7%
OCF(TTM)1.13
OCFY3.41%
SpS6.65
BVpS2.15
TBVpS1.44
PEG (NY)3.84
PEG (5Y)1.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.81% | ||
| ROE | 26.44% | ||
| ROCE | 13.89% | ||
| ROIC | 10.98% | ||
| ROICexc | 28.7% | ||
| ROICexgc | 179.19% | ||
| OM | 4.58% | ||
| PM (TTM) | 8.54% | ||
| GM | 79.45% | ||
| FCFM | 13.43% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score7
Asset Turnover2.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 308.7% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 296.65% | ||
| Profit Quality | 157.36% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | 22.45 |
F-Score7
WACC8.83%
ROIC/WACC1.24
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)590.91%
EPS 3YN/A
EPS 5Y60.48%
EPS Q2Q%1000%
EPS Next Y15.95%
EPS Next 2Y29.78%
EPS Next 3Y33.96%
EPS Next 5Y41.75%
Revenue 1Y (TTM)69.33%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%95.45%
Revenue Next Year58.8%
Revenue Next 2Y37.44%
Revenue Next 3Y31.76%
Revenue Next 5Y27.61%
EBIT growth 1Y359.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.19%
EBIT Next 3Y91.04%
EBIT Next 5Y64.69%
FCF growth 1Y322.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y241.69%
OCF growth 3YN/A
OCF growth 5YN/A